Appointment
Heading the second Cambridge site
Bicycle Therapeutics is a biotechnology company developing a new class of therapeutics based on its proprietary bicyclic peptides platform, headquartered in Cambridge, UK. Deeagan joins from Trevena, where she held the position of Senior VP Business development and Operations. Previously, she worked at GlaxoSmithKline. Deegan graduated from Cambridge University and holds an MBA from French business school INSEAD.